More recently, it was reported that HDAC9 is hypomethylated in hepatocellular carcinoma (Archer et al., 2010) suggesting that epigenetic modifications could represent another way to overexpress HDAC9. This evidence concerns the gene HDAC9 and hepatocellular carcinoma.